Valeria Ceolin

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

Letermovir Prophylaxis Does Not Hinder Immune Reconstitution While Reshaping Viral Infection Landscape in Children.

Letermovir Prophylaxis Does Not Hinder Immune Reconstitution While Reshaping Viral Infection Landscape in Children.

Journal: Transplantation and cellular therapy

Published: September 24, 2025

Bilateral facial palsy as presenting symptom of post-transplant relapsed acute myeloid leukemia treated with venetoclax: a case report and literature review.

Bilateral facial palsy as presenting symptom of post-transplant relapsed acute myeloid leukemia treated with venetoclax: a case report and literature review.

Journal: Annals of hematology

Published: June 03, 2025

Cyclosporine plus methotrexate versus cyclosporine alone for graft-versus-host disease prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation from an HLA-identical sibling.

Cyclosporine plus methotrexate versus cyclosporine alone for graft-versus-host disease prophylaxis in pediatric patients undergoing hematopoietic stem cell transplantation from an HLA-identical sibling.

Journal: Journal of cancer research and clinical oncology

Published: December 30, 2024

Emerging CART Therapies for Pediatric Acute Myeloid Leukemia.

Emerging CART Therapies for Pediatric Acute Myeloid Leukemia.

Journal: Journal of pediatric hematology/oncology

Published: April 04, 2024

The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.

The PedAL/EuPAL Project: A Global Initiative to Address the Unmet Medical Needs of Pediatric Patients with Relapsed or Refractory Acute Myeloid Leukemia.

Journal: Cancers

Published: November 20, 2023

Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatment.

Immune-mediated cytopenias (IMCs) after HSCT for pediatric non-malignant disorders: epidemiology, risk factors, pathogenesis, and treatment.

Journal: European journal of pediatrics

Published: December 21, 2022

Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia.

Outcome of chimeric antigen receptor T-cell therapy following treatment with inotuzumab ozogamicin in children with relapsed or refractory acute lymphoblastic leukemia.

Journal: Leukemia

Published: July 09, 2022

Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center.

Off-label and compassionate use of targeted anticancer therapies: The experience of an Italian pediatric cancer center.

Journal: Pediatric blood & cancer

Published: July 08, 2022

Guillain-Barré syndrome after bortezomib therapy in a child with relapsed acute lymphoblastic leukemia.

Guillain-Barré syndrome after bortezomib therapy in a child with relapsed acute lymphoblastic leukemia.

Journal: Pediatric hematology and oncology

Published: August 09, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026